SAB Biotherapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SABS and other ETFs, options, and stocks.About SABS
SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company, which engages in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. It produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases.
SABS Key Statistics
Stock Snapshot
As of today, SAB Biotherapeutics(SABS) shares are valued at $3.77. The company's market cap stands at 291.28M, with a P/E ratio of -1.53.
On 2026-08-05, SAB Biotherapeutics(SABS) stock moved within a range of $3.72 to $3.89. With shares now at $3.77, the stock is trading +1.3% above its intraday low and -3.2% below the session's peak.
Trading volume for SAB Biotherapeutics(SABS) stock has reached 283.8K, versus its average volume of 580.61K.
Over the past 52 weeks, SAB Biotherapeutics(SABS) stock has traded between a high of $5.15 and a low of $1.85.
Over the past 52 weeks, SAB Biotherapeutics(SABS) stock has traded between a high of $5.15 and a low of $1.85.
Analyst ratings
100%
of 12 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.